Covalent conjugation of reduced graphene oxide with oligos for current–volt signal determination on leukemia

Oncogene-mutated breakpoint cluster region protein gene (BCR/ABL) has been found in chronic myelogenous leukemia (CML) patients. In particular, b3a2 is a common mutation type with CML, tested in this research as deoxyribonucleic acid sensor to identify the specific b3a2 sequence by a suitable captur...

Full description

Saved in:
Bibliographic Details
Published inApplied physics. A, Materials science & processing Vol. 126; no. 8
Main Authors Liu, Cangchun, Gopinath, Subash C. B., Lakshmipriya, Thangavel, Anbu, Periasamy
Format Journal Article
LanguageEnglish
Published Berlin/Heidelberg Springer Berlin Heidelberg 01.08.2020
Springer Nature B.V
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Oncogene-mutated breakpoint cluster region protein gene (BCR/ABL) has been found in chronic myelogenous leukemia (CML) patients. In particular, b3a2 is a common mutation type with CML, tested in this research as deoxyribonucleic acid sensor to identify the specific b3a2 sequence by a suitable capture probe. The aminated capture probe was attached on interdigitated electrode surface through the chemical linker, glycidyloxypropyltrimethoxysilane. Covalently linked reduced graphene oxide (rGO) with target sequence was identified by the capture probe. The prepared rGO from vacuum-assisted low-temperature exfoliated graphite was characterized by field emission scanning electron microscope, field emission transmission electron microscope, energy-dispersive X-ray spectroscopy and fourier-transform infrared spectroscopy. The limit of detection with duplex formation was attained between 1 and 10 aM, and the saturation point was noticed from 10 fM. The sensitivity was calculated to be 1 aM. Further, control experiments with single-, triple- and complete mismatch-sequences instead of target complementary failed to yield the changes in current signal indicating the selective identification of targeted b3a2 sequence. This method of detection helps in identifying the minimal leukemia cells residual with CML patient.
ISSN:0947-8396
1432-0630
DOI:10.1007/s00339-020-03769-y